Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Diagnostics » HME-8251117
  • Global Infertility Treatment Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: October 2017 | Report Code: HME-8251117

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Infertility is the most common problem in the world that refrains couple of children. Many treatments have been available with different success rates. The infertility treatments include  intrauterine insemination (IUI),fertility drugs, in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), donor insemination (DI), egg (or embryo) donation and surrogacy. The global Infertility Treatment market is expected to rise at a CAGR of 10.6% during the forecast period 2016-2023. The recent advances in assisted reproductive technologies (ART) is positively impacting the infertility treatment market as it provides huge possibilities for successful treatment of  infertility, for Examples new technologies include oocyte donation, intracytoplasmic sperm injection , and embryo cryopreservation.These new technology advancement leads to improved methods of infertility treatment with less limitation that furthur increses its adoption.

The key factor driving the growth of global Infertility Treatment market is rising lifestyle disorders across the world. There is a rise in  stress levels and lifestyle shift, due to various risk factors such as  consumption of alcohol and drugs. Lifestyle modifications can have a high impact on wellbeing  and this also affects fertility levels of the males and females. Improper lifestyle leads to obesity, hormonal imbalance, over and underweight that not only leads to heart diseases, diabeties but also affects the reproductive health of a person that often leads to infertility. According to the health data organisation there is around 2.1 billion people that is 30% of the world’s population  are either overweight or obese globally.The rise in global obesity rates in the last few years has been widespread and  became a major publichealth epidemic in both the developing  and the developed countries. The highest proportion that is around 13% of the world’s obese people lived in the United States in 2015. India  and China  together accounts for 15% of the total  obese population across the world.Obesity affect fertility and it is one of the important factor that leads to improper hormonal balances and problems with ovulation, specifically for obese women who are having their first baby. Obesity and type 2 diabetes is associated with poly-cystic ovary syndrome (PCOS), one of  most common cause of infertility. Moreover, women even with type 1 diabetes who take high amount of insulin aare at high risk of getting PCOS. Many women with diabetes can conceive only when they have maintained a healthy body weight and controled diabetes.

Source: OBRC Analysis.

The report on global Infertility Treatment market includes procedure, product type , patient type and end-users.

Procedures types include:

  • Assisted Reproductive Technology
  • Artificial Insemination
  • Fertility Surgeries




Product types include:

  • Instruments
  • Media & Consumables
  • Accessories




Patient types include:

  • Female Infertility Treatment
  • Male Infertility Treatment



End-users of Infertility Treatment includes:

  • Fertility Centers
  • Hospitals and Clinics
  • Research Institutes
  • Cryobank





The revenue for the above end users are specific to the infertility treatment market. However, the total revenue of these end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up procedure, product and patient type.

The global Infertility Treatment market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America accounted for the largest share of the infertility treatment market globally in 2016, followed by Europe and Asia pacific. The factors driving the market in North America includes high healthcare expenditure in the region, declining fertility rates, technological advancements, and an increase in the number of same-sex couples. The factors driving the market in Europe includes rising adoption of costlier treatment ,availability of advanced and well equipped fertility clinics, better coverage for treatments & diagnosis and growing awareness regarding infertility treatments. Asia Pacific is anticipated to be the fastest growing region in the forecast period. It is due to rising economic growth in the Emerging countries of the region such as India, China, and Singapore. Moreover rising geriatric population, increasing smoking, and lifestyle-associated diseases give rise to increased incidence of male infertility.

Global Infertility Treatment market report covers segmentation analysis of procedure type, product type, patient type and end user. Report further covers segments of procedure type which includes Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgeries. The ART segment is the dominating sub segment in the procedure segment due to rising infertility and prevalence of lifestyle disorders that leads to decline in fertility rate, high success rate of ART procedures technological innovations in the field of IVF, growing adoption of procedures such as surrogacy by same-sex. For instance, As per the Centre of disease control and prevention there is around 1.6% of all infants born in the United States annually are conceived by using Assisted Reproductive Technology. Report further covers segments of product type which include  instruments, media & consumables, and accessories. Where as the end-user of Infertility Treatment include fertility centres, hospitals & clinics, research institutes, and cryobanks. etc. The fertility centres segment holds the largest share of the infertility treatment market in 2016. It is due to rising number of fertility centers across the world, increasing medical tourism the high success rates in fertility centers are the key factors driving the fertility centers segment. On the basis of patient type, the global market for infertility treatment is segmented into male patients and female patients. The female patients segment is the dominating patient type segment in 2016 due to the declining female fertility rates and the availability of various infertility treatment options in the market.

The major market players of the global Infertility Treatment market are:

  • THE COOPER COMPANIES INC.
  • COOK GROUP INCORPORATED
  • THERMO FISHER SCIENTIFIC, INC.
  • GENEA LIMITED
  • ESCO MICRO PTE. LTD.
  • OTHERS







These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, product and service launch is the key strategy adopted by the companies in the Infertility Treatment market.

For Example; In May 2016, The Cooper Companies, Inc. or Cooper Surgical had acquired the commercial assets of Recombine Inc., which is a clinical genetic testing company that specializes in carrier screening. Carrier screening refers to a kind of genetic test that is performed on individuals in-order to help predicting their chances of having a child with a genetic disorder. Testing is performed before pregnancy and is used by an infertility specialist and gynaecologist/obstetrician.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in Infertility Treatment market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as procedure, product type ,patient type and end-users. .
  • Identify and understandthe strength, opportunities, challenges and threat of the Infertility Treatment market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of voice communication segment market.
  • Detailed analysis of various the regulatory policies which are affecting the global Infertility Treatment market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global Infertility Treatment market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the Infertility Treatment market, with giving extensive SCOT analysisof key companies. 

Key findings of the global Infertility Treatment market:

  • The key factor driving the growth of global Infertility Treatment market is the rising lifestyle disorders across the world impacting reproductive health of the person.
  • North America is the largest market region for global Infertility Treatment market in terms of market revenue share.
  • The fertility centers segment is the leading end user segment.
  • Acquisition is the key strategy adopted by the companies in the Infertility Treatment market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL INFERTILITY TREATMENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. ROI ANALYSIS
2.6.6. GAP ANALYSIS
2.6.7. PATENT ANALYSIS
2.6.8. PRICING ANALYSIS
2.6.9. PIPELINE ANALYSIS
2.6.10. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. DECLINE IN FERTILITY RATES
3.1.2. RISING PUBLIC-PRIVATE INVESTMENTS, FUNDS, AND GRANTS
3.1.3. GROWING PUBLIC AWARENESS REGARDING INFERTILITY
3.1.4. INCREASING NUMBER OF FERTILITY CLINICS WORLDWIDE
3.1.5. TECHNOLOGICAL UPGRADATION IN INFERTILITY TREATMENT DEVICES
3.2. MARKET RESTRAINTS
3.2.1. EXPENSIVE ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS
3.2.2. GOVERNMENT REGULATIONS FOR CERTAIN INFERTILITY TREATMENT OPTIONS
3.3. MARKET OPPORTUNITIES
3.3.1. USE OF FERTILITY TREATMENT OPTIONS BY SAME-SEX COUPLES AND SINGLE PARENTS 
3.3.2. RISING OPPORTUNITIES IN EMERGING MARKETS
3.3.2.1. IMPROVING HEALTHCARE INFRASTRUCTURE
3.3.2.2. INCREASING MEDICAL TOURISM DUE TO LOW TREATMENT COSTS
3.4.   MARKET CHALLENGES 
3.4.1. GROWING CONCERNS RELATED TO A.R.T. PROCEDURES
3.4.2. REDUCTION IN EFFICACY AMONG OLDER WOMEN
 
4. MARKET SEGMENTATION 
4.1. GLOBAL INFERTILITY TREATMENT MARKET BY PROCEDURE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBALASSISTED REPRODUCTIVE TECHNOLOGY MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL ARTIFICIAL INSEMINATION MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBALFERTILITY SURGERIES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL INFERTILITY TREATMENT MARKET BY PRODUCT TYPE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL INSTRUMENTS MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL MEDIA & CONSUMABLESMARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBALACCESSORIESMARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.4. KEY CONCLUSIONS
4.3. GLOBAL INFERTILITY TREATMENT MARKET BY PATIENT TYPE
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL FEMALE INFERTILITY MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL MALE INFERTILITY MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.4. GLOBAL INFERTILITY TREATMENTMARKET BY ENDUSER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL  FRTILITY CENTERS MARKET 
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL HOSPITALS AND CLINICS MARKET 
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL RESEARCH INSTITUTE MARKET 
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
4.4.5.4. GLOBAL CRYOBANKS MARKET 
4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.4.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL INFERTILITY TREATMENT MARKETBY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. THE BAKER COMPANY, INC.(U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. COOK GROUP INCORPORATED (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. .THE COOPER COMPANIES INC.  (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.3.5. STRATEGIC ANALYSIS
7.4. ESCO MICRO PTE. LTD. (SINGAPORE)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. GENEA LIMITED (AUSTRALIA.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HALOTECH DNA SL (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. IRVINE SCIENTIFIC(U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. IVFTECH APS (DENMARK)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. IHMEDICAL A/S (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. PANTARHEI BIOSCIENCE B.V. (U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. KITAZATO (JAPAN)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS 
7.11.5. STRATEGIC ANALYSIS
7.12. RINOVUM WOMEN’S HEALTH, LLC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. SCSA DIAGNOSTICS, INC. (U.K.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS 
7.13.5. STRATEGIC ANALYSIS
7.14. THERMO FISHER SCIENTIFIC, INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. VITROLIFE AB (SWEDEN)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL INFERTILITY TREATMENT MARKET BY PROCEDURE 2014-2023 ($ MILLION)
2. GLOBALASSISTED REPRODUCTIVE TECHNOLOGYMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL ARTIFICIAL INSEMINATIONMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL FERTILITY SURGERIESMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL INFERTILITY TREATMENT MARKET BY  PRODUCT2014-2023 ($ MILLION)
6. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL MEDIA AND CONSUMABLES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL ACESSORIES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL INFERTILITY TREATMENT MARKET BY PATIENT TYPE  2014-2023 ($ MILLION)
10. GLOBAL FEMALE INFERTILITY TREATMNET MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL MALE INFERTILITY TREATMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL INFERTILITY TREATMENT MARKETBY ENDUSER 2014-2023 ($ MILLION)
13. GLOBAL FERTILITY CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL HOSPITALS AND CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL RESEARCH INSTITUTE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL  CRYOBANKS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. NORTH AMERICA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
18. EUROPE INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
19. ASIA PACIFIC INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
20. REST OF THE WORLD INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGYMARKET 2014-2023 ($ MILLION)
2. GLOBAL ARTIFICIAL INSEMINATION MARKET 2014-2023 ($ MILLION)
3. GLOBAL FERTILITY SURGERIES MARKET 2014-2023 ($ MILLION)
4. GLOBALINSTRUMENTS MARKET 2014-2023 ($ MILLION)
5. GLOBAL MEDIA & CONSUMABLES  MARKET 2014-2023 ($ MILLION)
6. GLOBAL ACCESSORIES MARKET 2014-2023 ($ MILLION)
7. GLOBAL FEMALE INFERTILITY TREATMENTMARKET 2014-2023 ($ MILLION)
8. GLOBAL MALE INFERTILITY TREATMENTMARKET 2014-2023 ($ MILLION)
9. GLOBALFERTILITY CENTERS MARKET 2014-2023 ($ MILLION)
10. GLOBALHOSPITALS AND CLINICS MARKET 2014-2023 ($ MILLION)
11. GLOBAL CRYOBANKSMARKET 2014-2023 ($ MILLION)
12. UNITED STATES (U.S.) INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
13. CANADA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
14. UNITED KINGDOM (UK) INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
15. FRANCE INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
16. GERMANY INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
17. RUSSIA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
18. R.O.E INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
19. INDIA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
20. CHINA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
21. JAPAN INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
22. AUSTRALIA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
23. ROAPAC INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
24. LATIN AMERICA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
25. MENA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion